↓ Skip to main content

Dove Medical Press

Dietary natural astaxanthin at an early stage inhibits N-nitrosomethylbenzylamine–induced esophageal cancer oxidative stress and inflammation via downregulation of NFκB and COX2 in F344 rats

Overview of attention for article published in OncoTargets and therapy, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
28 Mendeley
Title
Dietary natural astaxanthin at an early stage inhibits N-nitrosomethylbenzylamine–induced esophageal cancer oxidative stress and inflammation via downregulation of NFκB and COX2 in F344 rats
Published in
OncoTargets and therapy, July 2019
DOI 10.2147/ott.s197044
Pubmed ID
Authors

Lingling Cui, Fan Xu, Minkai Wang, Li Li, Tianyi Qiao, Han Cui, Zhonglei Li, Changqing Sun

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 11%
Student > Master 3 11%
Student > Bachelor 3 11%
Lecturer 2 7%
Student > Ph. D. Student 2 7%
Other 2 7%
Unknown 13 46%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 21%
Pharmacology, Toxicology and Pharmaceutical Science 3 11%
Biochemistry, Genetics and Molecular Biology 2 7%
Chemical Engineering 1 4%
Immunology and Microbiology 1 4%
Other 1 4%
Unknown 14 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2020.
All research outputs
#15,777,641
of 25,759,158 outputs
Outputs from OncoTargets and therapy
#843
of 3,014 outputs
Outputs of similar age
#197,582
of 364,986 outputs
Outputs of similar age from OncoTargets and therapy
#22
of 118 outputs
Altmetric has tracked 25,759,158 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,014 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,986 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.